Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12578
Title: Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial.
Authors: Milgrom, Jeannette;Gemmill, Alan W;Ericksen, Jennifer;Burrows, Graham D;Buist, Anne;Reece, John
Affiliation: Parent-Infant Research Institute, Department of Clinical & Health Psychology, Heidelberg Repatriation Hospital, Heidelberg West, Australia Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia jeannette.milgrom@austin.org.au.
Parent-Infant Research Institute, Department of Clinical & Health Psychology, Heidelberg Repatriation Hospital, Heidelberg West, Australia.
Department of Psychiatry, Austin Health, Melbourne, Australia Department of Psychiatry, University of Melbourne, Melbourne, Australia.
RMIT University & Australian College of Applied Psychology, Melbourne, Australia.
Issue Date: 13-Jan-2015
Citation: The Australian and New Zealand Journal of Psychiatry 2015; 49(3): 236-45
Abstract: Both antidepressant medications and psychological therapy are common treatments for depression in postpartum women. Antidepressant treatment may have a number of practical disadvantages, including a preference by women to avoid medication while breastfeeding. Consequently, more information about the relative benefits of the two modalities in the perinatal period is helpful. In the treatment of depressive disorders there is some evidence that combination therapies (pharmacological plus psychological treatment) may be more efficacious than either form of mono-therapy in isolation. However, in the treatment of postnatal depression, such evidence is limited.Forty five postpartum women with a DSM-IV diagnosis of depression were randomised to receive either: 1) cognitive behavioural therapy (CBT); 2) sertraline, or 3) a combination of both treatment modalities. Psychometric measures were collected weekly for 12 weeks, with a follow-up at 24 weeks.Symptoms of depression and anxiety were reduced to a significant degree following all three treatments. CBT mono-therapy was found to be superior to both sertraline mono-therapy and combination therapy after 12 weeks. The CBT mono-therapy group appeared to display the most rapid initial gains after treatment commencement.In this sample, a specialised CBT program for postnatal depression was found to be superior as a mono-therapy compared to sertraline, a commonly prescribed SSRI antidepressant. This is in contrast to previous studies which have found no detectable difference in the efficacies of drug and psychological treatment for postnatal depression. Unlike some previous work, this study allowed a statistically independent evaluation of CBT mono-therapy for postnatal depression compared to both antidepressant and combination therapy. In line with previous studies in postpartum women, there was no detectable advantage of combining pharmacological and psychological treatments in the short term.
Internal ID Number: 25586754
URI: http://ahro.austin.org.au/austinjspui/handle/1/12578
DOI: 10.1177/0004867414565474
URL: http://www.ncbi.nlm.nih.gov/pubmed/25586754
Type: Journal Article
Subjects: cognitive behavioural therapy
combined therapy
postnatal depression
sertraline
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.